First Light Asset Management, LLC — 13F Holdings & Portfolio
CIK 1600004 · latest 13F-HR filed 2026-08-14
First Light Asset Management, LLC manages $1.65B in 13F-reported U.S. long-equity assets across 31 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are NEO (10.89%), SIBN (8.06%), AXGN (7.72%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 2 new positions, exited 6, added to 24, and trimmed 2.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 201
EDINA, MN 55435
$1.65B
Long-equity book
31
Distinct positions
2026-06-30
Filed 2026-08-14
+2 / −6 / ↑24 / ↓2
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- NEOGENOMICS INC$107.0M +148.2%
- APOGEE THERAPEUTICS INC$74.9M +154.4%
- SI-BONE INC$65.0M +96.2%
- ENLIVEN THERAPEUTICS INC$61.1M +772.7%
- GUARDANT HEALTH$40.4M +155.9%
Exited Positions
- CENTESSA PHARMACEUTICALS LIMITED$62.0M
- WAVE LIFE SCIENCES LTD$13.4M
- VERA THERAPEUTICS INC$12.6M
- MIMEDX GROUP INC$11.2M
- SPYGLASS PHARMA INC$9.7M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | NEOGENOMICS INC | NEO | 64049M209 | $179.2M | 10.89% | 12,279,523 | SH |
| 2 | SI-BONE INC | SIBN | 825704109 | $132.6M | 8.06% | 8,127,985 | SH |
| 3 | AXOGEN INC | AXGN | 05463X106 | $126.9M | 7.72% | 2,748,361 | SH |
| 4 | APOGEE THERAPEUTICS INC | APGE | 03770N101 | $123.5M | 7.50% | 930,289 | SH |
| 5 | PALVELLA THERAPEUTICS INC | PVLA | 697947109 | $118.0M | 7.17% | 771,901 | SH |
| 6 | TWIST BIOSCIENCE CORPORATION | TWST | 90184D100 | $74.9M | 4.55% | 727,933 | SH |
| 7 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $69.1M | 4.20% | 1,360,750 | SH |
| 8 | GUARDANT HEALTH | GH | 40131M109 | $66.3M | 4.03% | 441,586 | SH |
| 9 | 908 DEVICES INC | MASS | 65443P102 | $54.7M | 3.32% | 6,282,804 | SH |
| 10 | AMYLYX PHARMACEUTICALS INC | AMLX | 03237H101 | $54.3M | 3.30% | 3,023,256 | SH |
| 11 | GENEDX HOLDINGS CORP | WGS | 81663L200 | $53.8M | 3.27% | 783,923 | SH |
| 12 | SIMULATIONS PLUS INC | SLP | 829214105 | $51.1M | 3.11% | 2,792,677 | SH |
| 13 | TANDEM DIABETES CARE INC | TNDM | 875372203 | $51.1M | 3.10% | 3,383,553 | SH |
| 14 | CRINETICS PHARMACEUTICALS INC | CRNX | 22663K107 | $50.9M | 3.10% | 1,360,866 | SH |
| 15 | NEUROPACE INC | NPCE | 641288105 | $45.5M | 2.76% | 2,861,167 | SH |
| 16 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $44.5M | 2.70% | 1,095,171 | SH |
| 17 | ANAPTYS BIO INC | ANAB | 032724106 | $39.3M | 2.39% | 582,004 | SH |
| 18 | TREVI THERAPEUTICS INC | TRVI | 89532M101 | $39.1M | 2.38% | 2,097,215 | SH |
| 19 | SEPTERNA INC | SEPN | 81734D104 | $32.3M | 1.96% | 963,260 | SH |
| 20 | TRISALUS LIFE SCIENCES INC | TLSI | 89680M101 | $29.8M | 1.81% | 6,552,491 | SH |
| 21 | TECTONIC THERAPEUTICS INC | TECX | 878972108 | $27.5M | 1.67% | 800,726 | SH |
| 22 | HEALTH CATALYST INC | HCAT | 42225T107 | $25.5M | 1.55% | 12,810,861 | SH |
| 23 | BUTTERFLY NETWORK INC | BFLY | 124155102 | $22.2M | 1.35% | 2,642,404 | SH |
| 24 | ESTABLISHMENT LABS HOLDINGS | ESTA | G31249108 | $21.2M | 1.29% | 246,577 | SH |
| 25 | VAXCYTE INC | PCVX | 92243G108 | $20.1M | 1.22% | 345,157 | SH |
| 26 | IRHYTHM TECHNOLOGIES | IRTC | 450056106 | $19.9M | 1.21% | 167,092 | SH |
| 27 | OMNICELL INC | OMCL | 68213N109 | $18.8M | 1.14% | 452,324 | SH |
| 28 | ATRICURE INC | ATRC | 04963C209 | $15.9M | 0.97% | 567,838 | SH |
| 29 | KORU MEDICAL SYSTEMS INC | KRMD | 759910102 | $14.2M | 0.86% | 3,387,902 | SH |
| 30 | TACTILE SYSTEMS TECHNOLOGY INC | TCMD | 87357P100 | $13.8M | 0.84% | 462,562 | SH |
| 31 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $9.5M | 0.58% | 85,765 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $1.65B | 31 | 0001999371-26-018014 |
| 2026-03-31 | 2026-05-15 | $1.12B | 35 | 0001999371-26-010896 |
| 2025-12-31 | 2026-02-17 | $1.31B | 33 | 0001999371-26-003511 |
| 2025-09-30 | 2025-11-14 | $1.06B | 41 | 0001999371-25-017920 |